MSU-43557
Based on 1 Customer Validation
MSU-43557 is a Mycobacterium abscessus MmpL3 (MAB_4508) inhibitor and bactericidal agent. MSU-43557 inhibits MmpL3 function, disrupts trehalose monomycolate synthesis, and reduces biofilm-associated Mycobacterium abscessus viability. MSU-43557 exerts bactericidal activity against intracellular Mycobacterium abscessus. MSU-43557 shows low eukaryotic cytotoxicity and low Mycobacterium abscessus resistance frequency. MSU-43557 can be used for the research of mycobacterium abscessus infection.
For research use only. We do not sell to patients.
- Purity : 99.74%
- CAS No.: 2919699-59-3
- Formula: C15H17Cl2N3O
- Molecular Weight:326.22
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
In Vitro
MSU-43557 (80 μM-0.08 nM; 3 d) potently inhibits the growth of Mycobacterium abscessus ATCC 19977 in vitro, and exhibits time-dependent bactericidal activity at a concentration of 5× MIC; meanwhile, MSU-43557 potently inhibits strains of Mycobacterium tuberculosis, Mycobacterium abscessus and Mycobacterium smegmatis, shows no activity against non-mycobacterial species within 80 μM, and displays variable inhibitory activity against clinically isolated multidrug-resistant Mycobacterium abscessus strains[1].
MSU-43557 (0.18 nM-160 μM; 3 d) disrupts mature Mycobacterium abscessus biofilms with an EC50 of 8.66 μM; it also reduces bacterial viability within biofilms, with a corresponding EC50 of 0.16 μM[1].
MSU-43557 (0.18 nM-160 μM; 3 d) kills intracellular Mycobacterium abscessus ATCC 19977 in mouse bone marrow-derived macrophages with an EC50 of 0.39 μM, and exhibits low cytotoxicity toward mouse bone marrow-derived macrophages[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Mycobacterium tuberculosis strains, Mycobacterium abscessus, and Mycobacterium smegma
-
Concentration:80 μM-0.08 nM
-
Incubation Time:3 d
-
Result:Inhibited the growth of Mycobacterium abscessus ATCC 19977 by an EC50 of 1.29 μM and a MIC of 3.69 μM.
Effectively inhibited Mycobacterium tuberculosis strains (EC50 value of 0.13 to 0.19 μM), Mycobacterium abscessus (EC50 of 1.82 μM), and Mycobacterium smegma (EC50 of 2.54 μM).
-
Cell Line:Murine bone marrow-derived macrophages (BMMΦ)
-
Concentration:200 to 0.13 μM
-
Incubation Time:3 d
-
Result:Resulted in a CC50 of >80 μM, indicating low cytotoxicity relative to intracellular efficacy.
Chemical Information
-
CAS No. 2919699-59-3
-
Appearance Solid
-
Molecular Weight 326.22
-
Formula C15H17Cl2N3O
-
Color White to off-white
-
SMILES
CC1(CCCCC1)C(NC2=NC3=CC(Cl)=C(Cl)C=C3N2)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
DMSO : 100 mg/mL (306.54 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
-
Data Sheet (274 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 3.0654 mL | 15.3271 mL | 30.6542 mL | 76.6354 mL |
| 5 mM | 0.6131 mL | 3.0654 mL | 6.1308 mL | 15.3271 mL | |
| 10 mM | 0.3065 mL | 1.5327 mL | 3.0654 mL | 7.6635 mL | |
| 15 mM | 0.2044 mL | 1.0218 mL | 2.0436 mL | 5.1090 mL | |
| 20 mM | 0.1533 mL | 0.7664 mL | 1.5327 mL | 3.8318 mL | |
| 25 mM | 0.1226 mL | 0.6131 mL | 1.2262 mL | 3.0654 mL | |
| 30 mM | 0.1022 mL | 0.5109 mL | 1.0218 mL | 2.5545 mL | |
| 40 mM | 0.0766 mL | 0.3832 mL | 0.7664 mL | 1.9159 mL | |
| 50 mM | 0.0613 mL | 0.3065 mL | 0.6131 mL | 1.5327 mL | |
| 60 mM | 0.0511 mL | 0.2555 mL | 0.5109 mL | 1.2773 mL | |
| 80 mM | 0.0383 mL | 0.1916 mL | 0.3832 mL | 0.9579 mL | |
| 100 mM | 0.0307 mL | 0.1533 mL | 0.3065 mL | 0.7664 mL |
Keywords
- MSU-43557
- 2919699-59-3
- MSU43557
- MSU 43557
- Bacterial
- Mycobacterium abscessus ATCC 19977
- mycolic acid transport
- Mycobacterium abscessus mmpL3 mutants
- biofilm-associated Mycobacterium abscessus
- MmpL3
- murine bone marrow-derived macrophages
- MAB_4508
- Mycobacterium abscessus
- intracellular Mycobacterium abscessus
- trehalose monomycolate synthesis
- Inhibitor
- inhibitor
- inhibit